Principal Investigators

    Savva, George


    South Norfolk CCG

    Contact information of lead PI


    United Kingdom

    Title of project or programme

    Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences

    Source of funding information


    Total sum awarded (Euro)

    € 480,627

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Alzheimer's disease & other dementias


    Research Abstract

    Background Between 600,000 and 800,000 people in England have dementia, yet only around 344,000 are recorded on dementia registers maintained by GPs. So a substantial proportion of people with dementia do not have a diagnosis. Closing this diagnosis gap is an NHS and Department of Health priority, but very little is known about the population with undiagnosed dementia, and there is little direct evidence regarding the benefits of a dementia diagnosis. Aims We will link data from an existing longitudinal cohort study (Medical Research Council Cognitive Function and Ageing Study; CFAS II) with primary care records to estimate the prevalence of undiagnosed dementia and its distribution among the older population of England, the barriers to diagnosis and the clinical and psychosocial impacts of diagnosis among people with dementia. Methods and research questions Around 460 participants of CFAS II received a study diagnosis of dementia between 2008 and 2012 and gave consent for their medical records to be examined. CFAS II is designed such that these participants are representative of the English population aged 65 and older with dementia. We will contact their GPs to ascertain whether dementia was suspected, diagnosed or recorded on dementia registers at the time of study diagnosis. CFAS II assessments include: • A comprehensive cognitive assessment • Informant reports of psychiatric and medical comorbidity (including history and treatment) and functional impairment • Behavioural and psychological assessment • Social participation and contacts • GMS/AGECAT dementia diagnosis: a widely used algorithmic dementia diagnosis, validated against Diagnostic and Statistical Manual (DSM) definitions and upon which many UK and global dementia prevalence estimates are currently based. From GP records we will extract and link: • Fact and date of dementia diagnosis and presence on QOF dementia registers • First mention of memory/cognitive impairment • Referrals to dementia services • Censoring events By combining these data we will answer the following questions: Primary objectives: • What was the prevalence of undiagnosed dementia between 2008 and 2012? • What are the associations between social and clinical characteristics of a person with dementia and their risk of being undiagnosed? • To what extent does the dementia register mandated by the quality outcomes framework (QOF) reflect GPs knowledge of cognitive impairment among their patients? Secondary objectives: • How are clinical and psychosocial trajectories over a two year follow-up period associated with diagnosis status among people with dementia? Dissemination and Impacts Our dissemination plan is designed to reach all relevant stakeholders to inform the policy debate around dementia diagnosis and the design and implementation of plans to achieve timely diagnosis of dementia for all. Timetable This work is expected to take 24 months. Months 1-5: Develop and pilot a data collection protocol, refine analysis objectives. Months 6-12: Data collection phase. Months 13-24: Data linkage, quality assurance, analysis, dissemination activities.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: United Kingdom
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF